The integration of platinum and radiotherapy in the treatment of lung cancer.
Publication/Presentation Date
2-1-1991
Abstract
Combined-modality therapy in lung cancer is a common practice throughout the world. The use of radiochemotherapy appears to be firmly established in the treatment of small cell lung cancer, but the role of prophylactic cranial irradiation remains undecided. Many recommend its use in the treatment of non-small cell lung cancer as well, but no facts exist to support this position. Because of poor long-term outcome and high frequency of systemic relapse, integration of chemotherapy for the treatment of non-small cell lung cancer is becoming more prevalent. This article discusses methods of integration, the problems of combined- modality toxicity, recent trials, and reports of multimodal therapy in lung cancer. The advantages of certain regimens of chemotherapy and new methods of radiotherapy are also discussed.
Volume
18
Issue
1 Suppl 3
First Page
81
Last Page
87
ISSN
0093-7754
Published In/Presented At
Turrisi A. T., 3rd (1991). The integration of platinum and radiotherapy in the treatment of lung cancer. Seminars in oncology, 18(1 Suppl 3), 81–87.
Disciplines
Medicine and Health Sciences
PubMedID
2003231
Department(s)
Department of Medicine
Document Type
Article